Bank Of New York Mellon Corp Adamis Pharmaceuticals Corp Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.1 - $0.3 $8,400 - $25,200	84,002 New	84,002 $9.74 Million
Q4 2022 Feb 14, 2023	BUY	$0.14 - $0.22 $11,760 - $18,480	84,002 New	84,002 $14,000
Q2 2021 Aug 11, 2021	BUY	$0.66 - $1.23 $37,841 - $70,523	57,336 Added 215.02%	84,002 $92,000
Q1 2019 May 14, 2019	SELL	$2.02 - $3.22 $1,611 - $2,569	-798 Reduced 2.91%	26,666 $56,000
Q2 2018 Aug 06, 2018	SELL	$3.2 - $4.7 $15,904 - $23,359	-4,970 Reduced 15.32%	27,464 $88,000

Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $10,824 - $20,588	4,245 Added 15.06%	32,434 $113,000
Q4 2017 Feb 09, 2018	BUY	$3.5 - $5.65 $98,661 - $159,267	28,189	28,189 $124,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.